Allowing states to define “essential health benefits” could weaken ACA protections against catastrophic costs for people with employer coverage nationwide Matthew Fiedler Tuesday, May 2, 2017
Can drug importation address high generic drug prices? Thomas Bollyky and Aaron Kesselheim Tuesday, May 2, 2017
Enabling competition in pharmaceutical markets Fiona Scott Morton and Lysle Boller Tuesday, May 2, 2017
“Right-to-try” warrants FDA oversight for experimental treatments Jack Karsten and Darrell M. West Monday, April 24, 2017
The essential scan: Top findings in health policy research Margaret Darling, Stephanie Hedt, and Paul B. Ginsburg Thursday, April 20, 2017
To promote stability in health insurance exchanges, end the uncertainty around cost-sharing and other rules Erin Trish, Loren Adler, and Paul B. Ginsburg Thursday, April 20, 2017
Making health care markets work: Competition policy for health care Martin Gaynor, Farzad Mostashari, and Paul B. Ginsburg Thursday, April 13, 2017
